| The primary hyperoxalurias B Hoppe, BB Beck, DS Milliner Kidney international 75 (12), 1264-1271, 2009 | 454 | 2009 |
| Bone mineral content per muscle cross‐sectional area as an index of the functional muscle‐bone unit E Schoenau, CM Neu, B Beck, F Manz, F Rauch Journal of bone and mineral research 17 (6), 1095-1101, 2002 | 387 | 2002 |
| Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy O Gross, C Licht, HJ Anders, B Hoppe, B Beck, B Tönshoff, B Höcker, ... Kidney international 81 (5), 494-501, 2012 | 381 | 2012 |
| Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1 B Hoppe, B Beck, N Gatter, G Von Unruh, A Tischer, A Hesse, N Laube, ... Kidney international 70 (7), 1305-1311, 2006 | 255 | 2006 |
| ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling HY Gee, P Saisawat, S Ashraf, TW Hurd, V Vega-Warner, H Fang, ... The Journal of clinical investigation 123 (8), 3243-3253, 2013 | 252 | 2013 |
| Diagnosis and metaphylaxis of stone disease: Consensus concept of the National Working Committee on Stone Disease for the Upcoming German Urolithiasis Guideline M Straub, WL Strohmaier, W Berg, B Beck, B Hoppe, N Laube, S Lahme, ... World journal of urology 23, 309-323, 2005 | 244 | 2005 |
| Nephrocalcinosis and urolithiasis in children S Habbig, BB Beck, B Hoppe Kidney international 80 (12), 1278-1291, 2011 | 211 | 2011 |
| Polyhydramnios, Transient Antenatal Bartter’s Syndrome, and MAGED2 Mutations K Laghmani, BB Beck, SS Yang, E Seaayfan, A Wenzel, B Reusch, ... New England Journal of Medicine 374 (19), 1853-1863, 2016 | 194 | 2016 |
| Muscle analysis by measurement of maximal isometric grip force: new reference data and clinical applications in pediatrics F Rauch, CM Neu, G Wassmer, B Beck, G Rieger-Wettengl, E Rietschel, ... Pediatric research 51 (4), 505-510, 2002 | 161 | 2002 |
| Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice H Hoyer-Kuhn, S Kohbrok, R Volland, J Franklin, B Hero, BB Beck, ... Clinical Journal of the American Society of Nephrology 9 (3), 468-477, 2014 | 151 | 2014 |
| Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15 C Licht, A Weyersberg, S Heinen, L Stapenhorst, J Devenge, B Beck, ... American journal of kidney Diseases 45 (2), 415-421, 2005 | 147 | 2005 |
| Rapid response to cyclosporin a and favorable renal outcome in nongenetic versus genetic steroid–resistant nephrotic syndrome AK Büscher, BB Beck, A Melk, J Hoefele, B Kranz, D Bamborschke, ... Clinical Journal of the American Society of Nephrology 11 (2), 245-253, 2016 | 138 | 2016 |
| Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type G Mandrile, CS Van Woerden, P Berchialla, BB Beck, CA Bourdain, ... Kidney international 86 (6), 1197-1204, 2014 | 124 | 2014 |
| C3 deposition glomerulopathy due to a functional factor H defect S Habbig, MJ Mihatsch, S Heinen, B Beck, M Emmel, C Skerka, ... Kidney international 75 (11), 1230-1234, 2009 | 123 | 2009 |
| A molecular mechanism explaining albuminuria in kidney disease L Butt, D Unnersjö-Jess, M Höhne, A Edwards, J Binz-Lotter, D Reilly, ... Nature metabolism 2 (5), 461-474, 2020 | 121 | 2020 |
| Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin AB Ekici, T Hackenbeck, V Moriniere, A Pannes, M Buettner, S Uebe, ... Kidney international 86 (3), 589-599, 2014 | 114 | 2014 |
| Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity DA Braun, M Schueler, J Halbritter, HY Gee, JD Porath, JA Lawson, ... Kidney international 89 (2), 468-475, 2016 | 101 | 2016 |
| Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity BB Beck, FJ van Spronsen, A Diepstra, RMF Berger, M Kömhoff Pediatric nephrology 32, 733-741, 2017 | 98 | 2017 |
| Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies BB Beck, A Baasner, A Buescher, S Habbig, N Reintjes, MJ Kemper, ... European Journal of Human Genetics 21 (2), 162-172, 2013 | 94 | 2013 |
| Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn’s disease R Hueppelshaeuser, GE von Unruh, S Habbig, BB Beck, S Buderus, ... Pediatric nephrology 27, 1103-1109, 2012 | 94 | 2012 |
